Edwards Lifesciences amends bylaws to adopt universal proxy rules and update advance notice provisions

Edwards Lifesciences Corp

Bylaws amended to incorporate Rule 14a-19 universal proxy requirements for director nominations.
Stockholders must provide evidence of compliance with universal proxy rules, including soliciting at least 67% voting power.
Advance notice provisions updated with additional disclosure requirements for nominees and proposing stockholders.
Company may require proposed nominees to submit to interviews with the Board or a committee.
Other technical and conforming changes to align with recent amendments to Delaware General Corporation Law.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Edwards Lifesciences Corp: Amended and restated Bylaws to incorporate universal proxy rule (Rule 14a-19) and update advance notice provisions for director nominations, including new disclosure and compliance requirements (effective 2023-02-16).

Change: bylaw amendment
Effective: 2023-02-16

Exact text from the filing

On February 16, 2023, the Board of Directors (the “Board”) of Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), amended and restated the Company’s Bylaws (as so amended and restated, the “Bylaws”).

View on SEC.gov

Browse all governance changes →

Edwards Lifesciences Corp filing history →

Source: SEC EDGAR

accession 0001193125-23-043538

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.